H Oman
Overview
Explore the profile of H Oman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
420
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Johansson S, Oman H, Degerbeck F, Tunelli J, Florvaag E, Nopp A
Acta Anaesthesiol Scand
. 2012 Jan;
56(2):262-3.
PMID: 22236348
No abstract available.
2.
Ankerst J, Nopp A, Johansson S, Adedoyin J, Oman H
Int Arch Allergy Immunol
. 2009 Nov;
152(1):71-4.
PMID: 19940508
Background: Two atopic patients suffering from severe allergy difficult to handle by conventional medication were given Xolair despite an IgE level <30 kU/l. Methods: Increasing dosages were given and monitored...
3.
Johansson S, Nopp A, Oman H, Stahl-Skov P, Hunting A, Guttormsen A
Allergy
. 2009 Oct;
65(1):124-9.
PMID: 19804438
Background: Patent Blue V (PBV) is injected in order to map sentinel nodes during cancer staging procedures. Anaphylactic reactions, allegedly IgE antibody mediated, have been reported. The aim of the...
4.
Johansson S, Florvaag E, Oman H, Poulsen L, Mertes P, Harper N, et al.
Allergy
. 2009 Oct;
65(4):498-502.
PMID: 19796197
Background: The aim of this study was to test, on a multinational level, the pholcodine (PHO) hypothesis, i.e. that the consumption of PHO-containing cough mixtures could cause higher prevalence of...
5.
Nopp A, Johansson S, Adedoyin J, Ankerst J, Palmqvist M, Oman H
Allergy
. 2009 Oct;
65(1):56-60.
PMID: 19796193
Background: This study reports the clinical and immunological state of patients 3 years after a 6-year period of Xolair treatment for severe allergic asthma. Methods: The patient's cat allergen sensitivity,...
6.
Johansson S, Nopp A, Oman H, Ankerst J, Cardell L, Gronneberg R, et al.
Allergy
. 2009 Apr;
64(10):1472-1477.
PMID: 19393000
Background: Some patients with allergic asthma treated with anti-IgE (Xolair) do not become symptom free. Better criteria for response assessment than allergy skin tests or IgE determination are needed. The...
7.
Nopp A, Cardell L, Johansson S, Oman H
Allergy
. 2009 Feb;
64(5):811-4.
PMID: 19220221
Background: Allergen-specific immunotherapy (ASIT) in allergic rhinitis and asthma is the only treatment that effects the long-term development of these diseases. Basophil allergen threshold sensitivity, CD-sens, which is a valuable...
8.
Johansson S, Oman H, Nopp A, Florvaag E
Allergy
. 2009 Feb;
64(5):820-1.
PMID: 19210354
No abstract available.
9.
Rodrigues-Alves R, Pregal A, Pereira-Santos M, Branco-Ferreira M, Lundberg M, Oman H, et al.
Allergol Immunopathol (Madr)
. 2008 May;
36(2):113-6.
PMID: 18479664
The use of pine nuts, the seeds of Pinus pinea, is on the increasing in the modern Mediterranean diet. Little more than 20 cases of allergy to this tree nut...
10.
Harboe T, Johansson S, Florvaag E, Oman H
Allergy
. 2007 Nov;
62(12):1445-50.
PMID: 17983379
Background: Neuromuscular blocking agents (NMBAs) can cause anaphylaxis through immunoglobulin E (IgE) antibodies that bind quaternary ammonium ion epitopes. These epitopes are present in numerous common chemicals and drugs, exposure...